Autologous adipose-derived stem cells therapy in COPD treatment: a case report.

Autor: Nguyen TT; Hanoi Medical University Hanoi Vietnam.; Bach Mai Hospital Hanoi Vietnam., Phan PT; Hanoi Medical University Hanoi Vietnam.; Bach Mai Hospital Hanoi Vietnam., Nguyen BH; Hanoi Medical University Hanoi Vietnam.; Bach Mai Hospital Hanoi Vietnam., Vu TTT; Hanoi Medical University Hanoi Vietnam.; Bach Mai Hospital Hanoi Vietnam., Pham PC; Hanoi Medical University Hanoi Vietnam.; Bach Mai Hospital Hanoi Vietnam., Van Vu G; Hanoi Medical University Hanoi Vietnam.; Bach Mai Hospital Hanoi Vietnam., Nguyen KB; National Institute of Hematology and Blood Transfusion Hanoi Vietnam., Vu TT; Bach Mai Hospital Hanoi Vietnam., Vu LD; Bach Mai Hospital Hanoi Vietnam., Ngo CQ; Hanoi Medical University Hanoi Vietnam.
Jazyk: angličtina
Zdroj: Respirology case reports [Respirol Case Rep] 2021 Apr 28; Vol. 9 (5), pp. e00748. Date of Electronic Publication: 2021 Apr 28 (Print Publication: 2021).
DOI: 10.1002/rcr2.748
Abstrakt: Here, we describe the clinical course of a patient with chronic obstructive pulmonary disease treated with autologous adipose-derived stem cell therapy. In September 2019, our patient was admitted to Bach Mai Hospital. His post-bronchodilator forced expiratory volume in 1 sec (FEV 1 ) was 21% and FEV 1 /forced vital capacity (FVC) was 40%. He had suffered from two exacerbations of chronic obstructive pulmonary disease (COPD) in the previous year. He received treatment with autologous stem cells from adipose tissue. Follow-up indicated that autologous stem cells from adipose tissue was a safe treatment and improved the patient's dyspnoea and quality of life.
(© 2021 The Authors. Respirology Case Reports published by John Wiley & Sons Australia, Ltd on behalf of The Asian Pacific Society of Respirology.)
Databáze: MEDLINE
Externí odkaz: